Use of antisense in vitro for inhibition of hepatitis C virus replication

Ahmed Mohamed Fahmy;

Abstract


Introduction: Although interferon and ribavirin combined therapy is the only approved HCV therapy, this therapy is costly, prolonged, and is associated with significant adverse effects. Furthermore; its outcome is unfortunately poor with genotype 4. Deve


Other data

Title Use of antisense in vitro for inhibition of hepatitis C virus replication
Other Titles استخدام الشفرة العكسية لتثبيط تكاثر الفيروس الكبدي سي معمليا
Authors Ahmed Mohamed Fahmy
Keywords Use of antisense in vitro for inhibition of hepatitis C virus replication
Issue Date 2009
Description 
Introduction: Although interferon and ribavirin combined therapy is the only approved HCV therapy, this therapy is costly, prolonged, and is associated with significant adverse effects. Furthermore; its outcome is unfortunately poor with genotype 4. Deve

Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check

views 2 in Shams Scholar


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.